T1	intervention 35 62	hormone replacement therapy
T2	outcome 1638 1659	died of breast cancer
T3	iv-bin-abs 1610 1613	six
T4	iv-bin-abs 1664 1667	six
T5	outcome 1684 1702	distant metastases
T6	outcome 1498 1530	Cumulative incidences at 5 years
T7	iv-bin-percent 1536 1541	22.2%
T8	cv-bin-percent 1560 1564	8.0%
T9	outcome 1441 1464	new breast cancer event
T12	iv-bin-abs 1341 1352	Thirty-nine
T13	intervention-participants 1360 1363	221
T14	cv-bin-abs 1388 1390	17
T15	control-participants 1398 1401	221
T16	total-participants 1265 1268	447
T17	total-participants 1294 1297	442
T20	eligibility 383 426	women with previously treated breast cancer
T10	cv-bin-abs 1724 1728	five
T11	outcome 1739 1760	died of breast cancer
T18	cv-bin-abs 1765 1769	four
T21	outcome 1774 1798	metastatic breast cancer
T22	control 1415 1426	control arm
